Dr. Pierre is available for public speaking and Continuing Medical Education (CME) events on topics related to psychiatry and mental illness, psychotic disorders, cannabis and cannabis-induced psychosis, delusion-like beliefs and conspiracy theories, and suicide prevention.

Selected speaking events:

◉ “Conspiracy theories gone wild: Who believes them, why, and how we can help?”

American Psychiatric Association Annual Meeting; New York, NY; May 4, 2024.

◉ “Conspiracy theory beliefs: A sane response to an insane society?”

Workshop on Conspiratorial Thinking & Origins, Spread, and Consequences; California Institute of Technology, Pasadena, CA; September 14-15, 2023.

◉ “Are conspiratorial beliefs pathological?”

University of Birmingham, UK; April 24-25, 2023.

◉ “Conspiracy theories gone wild: Belief, ideology, and threat assessment”

Association of Threat Assessment Professionals Winter Conference; Orlando, FL; February 8, 2023

◉ “Uniting America to avoid, or if needed, win the next war” (panel discussion)

St. Francis Yatch Club Stag Cruise Light House Talks; September 24, 2022

◉ “Why have false beliefs and conspiracy theories become so powerful?”

The Commonwealth Club of California; September 1, 2022

◉ “Conspiracy theories gone wild: Belief, ideology, and intervention”

International Forensic Psychiatry Lecture Series; McMaster University; June 2, 2022.

◉ “Synthetic cannabinoids: Smoking guns, moving targets”

Webinar on New Psychoactive Substances: Synthetic stimulants/synthetic cannabinoids; International Society of Substance Use Professionals; May 27, 2022.

“Rabbit holes, red pills, and radicalization: Psychiatric aspects of extremism and conspiracy theorists”

American Psychiatric Association Annual Meeting; New Orleans, LA; May 25, 2022

◉ “Medical conspiracy theories”

DeVos Medical Ethics Colloquy; Grand Valley State University; March 21, 2022

◉ “Conspiracy theories”

Cambridge Disinformation Summit Webinar 1; University of Cambridge, Judge Business School; January 27, 2022

◉ “Conspiracy theories in clinical practice”

Maryland Psychological Association Annual Convention; November 3, 2021.

◉ “Is technology making you sick? A discussion on how tech is impacting our lives”

Ethics and Society Online Community Speaker Series, Community Memorial Healthcare System; October 14, 2021.

◉ “Civil rights movements and conspiracy theories

Panel Discussion Member; Creative Disruption and Social Movements Programme, Big Innovation Centre; UK. September 16, 2021.

◉ “Conspiracy theories: Mistrust, misinformation, and mitigation”

Grand Rounds, Department of Psychiatry and Biobehavioral Science, David Geffen School of Medicine at UCLA; February 25, 2020.

◉ “Suicide: Conceptual issues, risk assessment, and prevention”

Valley Hospital Medical Center Medical Conference, Rancho Palos Verdes, CA; July 30, 2021.

◉ “Conspiracy theories during COVID-19: Mistrust and misinformation”

7th Mandate—Commission for Citizenship, Governance, Institutional and External Affairs (CIVEX); February 16, 2021.

◉ “COVID and conspiracy theories”

UK Science Festivals Network Conference (online lecture); January 19, 2021.

◉ “Exploring scientific authority: From skepticism to conspiracy theory”

Science Events Summit, San Diego, CA; May 28, 2019.

◉ “Reefer madness 2020: Cannabinoids, synthetic cannabinoids, and psychosis”

California Association of Toxicologists Meeting Fall 2019; Oxnard, CA; November 4, 2019.

◉ “Marijuana in mental health”

Clinical Updates in Psychopharmacology, 31st Annual Premier Conference of the California Psychiatric Association, Dana Point, CA; September 21, 2018.

◉ “Real-world challenges in managing ‘dual diagnosis’ patients”

MDedge: News and Insights for Busy Physicians; September 5-12, 2018.

◉ “Cannabis for psychiatrists: Marijuana in mental health”

Psychopharmacology Update 29, Southern California Psychiatric Society, Los Angeles, CA; January 27, 2018.

◉ “Cannabis and psychosis: Potent risk, potential therapy”

UCLA Cannabis Research Symposium, Los Angeles, CA; April 20, 2017.

◉ “Underrepresented minority recruitment: Rationale, challenges, and strategies” 

Workshop Chair; 43rd Annual Meeting of the American Association of Directors of Psychiatric Residency Training, Tucson, AZ; March 14, 2014. 

◉ “Managing the side effects of antipsychotic medications”

111th Annual Florida Osteopathic Medical Association Convention, Westin, FL; February 20, 2014.

◉ “The pragmatic context of psychiatric diagnosis”

Symposium S19: Philosophical and Pragmatic Problems for DSM-5; 165th Annual Meeting American Psychiatric Association, Philadelphia, PA; May 5, 2012.